RNA interference treatment in primary hyperoxaluria type 1

被引：0
|
作者：
Monteverde, Marta Lidia [1 ]
机构：
[1] Hosp Juan P Garraham, Jefa Clin, Nefrol, Buenos Aires, Argentina
来源：
REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2023年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [31] The efficacy of denosumab treatment for hypercalcemia in a patient with primary hyperoxaluria type 1
    Rozhinskaya, Liudmila
    Gronskaia, Sofia
    Grebennikova, Tatiana
    Belaya, Zhanna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 116 - 116
  • [32] SUCCESSFUL EARLY TREATMENT WITH STIRIPENTOL IN A PATIENT WITH PRIMARY HYPEROXALURIA TYPE 1
    Violier, Priscillia
    Boyer, Olivia
    Berthaud, Romain
    Samaille, Charlotte
    Novo, Robert
    Dorval, Guillaume
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3358 - 3358
  • [33] Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
    Cochat, Pierre
    Hulton, Sally-Anne
    Acquaviva, Cecile
    Danpure, Christopher J.
    Daudon, Michel
    De Marchi, Mario
    Fargue, Sonia
    Groothoff, Jaap
    Harambat, Jerome
    Hoppe, Bernd
    Jamieson, Neville V.
    Kemper, Markus J.
    Mandrile, Giorgia
    Marangella, Martino
    Picca, Stefano
    Rumsby, Gill
    Salido, Eduardo
    Straub, Michael
    van Woerden, Christiaan S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1729 - 1736
  • [34] European and American approval for new treatment for Primary Hyperoxaluria Type 1
    不详
    BJU INTERNATIONAL, 2021, 127 (04) : 401 - 401
  • [35] Molecular etiology of primary hyperoxaluria type 1: New directions for treatment
    Danpure, CJ
    AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (03) : 303 - 310
  • [36] Mechanisms and treatment of type I primary hyperoxaluria
    Dallaporta, B
    Lang, P
    PRESSE MEDICALE, 1996, 25 (22): : 1033 - 1038
  • [37] SAFETY AND EFFICACY STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
    Frishberg, Yaacov
    Deschenes, Georges
    Cochat, Pierre
    Magen, Daniella
    Groothoff, Jaap
    Hulton, Sally A.
    Harambat, Jerome
    Hoff, William Vant
    Hoppe, Bernd
    Lieske, John C.
    McGregor, Tracy L.
    Haslett, Patrick
    Talamudupula, Sandeep
    Erbe, David V.
    Milliner, Dawn S.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E174 - E174
  • [38] EPIDEMIOLOGY OF PRIMARY HYPEROXALURIA TYPE-1
    COCHAT, P
    DELORAINE, A
    ROTILY, M
    OLIVE, F
    LIPONSKI, I
    DERIES, N
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 3 - 7
  • [39] Lumasiran: A Review in Primary Hyperoxaluria Type 1
    Kang, Connie
    DRUGS, 2024, 84 (02) : 255 - 255
  • [40] Transplantation procedures in primary hyperoxaluria type 1
    Latta, A
    MullerWiefel, DE
    Sturm, E
    Kemper, M
    Burdelski, M
    Broelsch, CE
    CLINICAL NEPHROLOGY, 1996, 46 (01) : 21 - 23
12345